CRNX Stock Analysis: Buy, Sell, or Hold?
CRNX - Crinetics Pharmaceuticals, Inc.
$83.71
0.04 (0.05%)
▲
5d:
+0.22%
30d:
+149.66%
90d:
+116.53%
WAIT
LOW Confidence
Analysis Updated: Jul 14, 2026 12:00 AM ET
Earnings: Aug 04, 2026
19d
Smart Money Distribution
None View Scanner →
Strength: 7.6/10
Get Alerted When CRNX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR BETTER ENTRY: CRNX is 24.6% above its trading range ($67.18). While momentum could continue, risk/reward favors waiting for a pullback.
⏸️ WAIT FOR BETTER ENTRY: CRNX is 24.6% above its trading range ($67.18). While momentum could continue, risk/reward favors waiting for a pullback.
In-depth Analysis How we analyze
Valuation Analysis: CRNX is currently trading at $83.71, which is considered extended relative to its 30-day fair value range of $26.93 to $67.18.
Technical Outlook: Technically, CRNX is in a downtrend. The price is approaching resistance at $83.77. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: CRNX has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, CRNX is in a downtrend. The price is approaching resistance at $83.77. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: CRNX has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$26.93 -
$67.18
Company Quality Score
53/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
47.4%
All Signals
- BEARISH: Price significantly overextended (+24.6% above its trading range)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($82.50)
- WARNING: Recommendation downgraded due to 24.6% overvaluation
Trading Range Analysis
30-Day Trading Range
$26.93 -
$67.18
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$36.68
Resistance Level
$83.77
Current Trend
Downtrend
Technical data as of
Jul 14, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-20.57
Wall Street Target
$82.50
(-1.4%)
Revenue Growth (YoY)
2873.4%
Share & Embed Analysis
Last updated: July 15, 2026 1:09 AM ET
Data refreshes hourly during market hours. Next update: 2:09 AM
Data refreshes hourly during market hours. Next update: 2:09 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CRNX showing a specific setup today?
Insider Activity (6 Months)
1
Buys
7
Sells
Net
INSIDERS SELLING
Recent Transactions
Jeff E Knight
SELL
85163 shares
2026-04-08
Jeff E Knight
SELL
9911 shares
2026-03-16
Richard Scott Struthers
SELL
21981 shares
2026-03-16
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$413 | 54 HOLD |
|
INSM
Insmed Inc |
STRONG BUY
21 analysts |
$197 | 54 HOLD |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$93 | 61 BUY |
|
BNTX
BioNTech SE |
STRONG BUY
21 analysts |
$122 | 52 HOLD |
|
APLS
Apellis Pharmaceuticals … |
BUY
22 analysts |
$41 | 59 HOLD |
